The global calcineurin inhibitors market is expanding due to the rising number of organ transplants and autoimmune diseases. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are medicines that help prevent organ rejection and reduce inflammation by suppressing the immune system. These drugs are widely used in treating conditions like psoriasis, eczema, and rheumatoid arthritis. Growing healthcare awareness, improved medical facilities, and ongoing research are driving market growth. However, side effects and high treatment costs may limit their use. Overall, the market is expected to grow steadily as the demand for effective immune-suppressing drugs continues worldwide.